Skip to content

Evaluation of the effectiveness of a self-help smartphone app on self-esteem among Polish-speaking users: a randomized controlled trial.

Evaluation of the effectiveness of a self-help smartphone app on self-esteem among Polish-speaking users: a randomized controlled trial. - COGITO-Poland

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00029996
Enrollment
220
Registered
2022-09-08
Start date
2022-09-15
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low self-esteem

Interventions

Group 1: Interventional: For both intervention groups (with and without mental health problems): Self-help smartphone app for mental health treatment and mental health crisis protection. The app "COG
use of standard outpatient care during the intervention period is allowed (treatment as ususal
TAU)

Sponsors

Universitätsklinikum Hamburg-Eppendorf Klinik und Poliklinik für Psychiatrie und PsychotherapieArbeitsgruppe Klinische Neuropsychologie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Informed consent, age between 18 and 85 years, sufficient level of Polish language, access to the internet and smartphone, willingness to participate in two anonymous online surveys, willingness to participate in the 6-week self-help smartphone app intervention, willingness to use the self-help smartphone app at one' s own responsibility, willingness to leave an anonymous email address for the survey.

Exclusion criteria

Exclusion criteria: Exclusion criteria are: acute suicidality (measured with the PHQ-9 item 9, cut-off > 2).

Design outcomes

Secondary

MeasureTime frame
Secondary outcome parameters will include the Patient Health Questionnaire-9 Depression Module (PHQ-9) to assess the severity of depressive symptoms (T0 and T1), the global item of the WHOQOL-BREF to measure quality of life (T0 and T1), the Attitude towards Psychological Online Interventions Questionnaire (APOI; T0), and the Patient Expectation and Evaluation of Therapy Questionnaire (PATHEV; T0). At T0, sociodemographic data and psychotherapy experience (self-report) will also be assessed. Individual access to psychotherapeutic treatment (self-report) will be surveyed at the two study time points (T0 and T1). At T1, possible side effects are to be evaluated by the Inventory for the Assessment of Negative Effects of Psychotherapy (INEP), and patient satisfaction is to be assessed by the Questionnaire for the Measurement of Patient Satisfaction (ZUF-8). Further explorations As part of the study, possible changes in the problem areas listed below will also be explored. The scales to be used are indicated in the brackets. Psychotic experience (The Community Assessment of Psychic Experiences, CAPE), generalized anxiety (Generalized Anxiety Disorder Screener, GAD-7), chronic pain (German Pain Questionnaire: Deutscher Schmerzfragebogen, DSF), problem gambling (Pathologic Gambling-Modification of the Yale-Brown Obsessive-Compulsive Scale, PG-YBOCS), and obsessive-compulsive disorder (Obsessive-Compulsive Inventory-4, OCI-4).

Primary

MeasureTime frame
The primary outcome parameter will be the Rosenberg Self-Esteem Scale (RSE) measuring self-esteem (T0 and T1) to elicit the expression of self-esteem in the last week (at T0 and T1 after 6 weeks).

Countries

Poland

Contacts

Public ContactSteffen Moritz

Universitätsklinikum Hamburg-Eppendorf Klinik und Poliklinik für Psychiatrie und PsychotherapieArbeitsgruppe Klinische Neuropsychologie

moritz@uke.de+49 40 7410 56565

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026